Quantum-Si incorporated

NasdaqGM:QSI Rapport sur les actions

Capitalisation boursière : US$187.5m

Quantum-Si Gestion

Gestion contrôle des critères 3/4

Le PDG Quantum-Si est Jeff Hawkins, nommé en Oct2022, a un mandat de 3.58 ans. La rémunération annuelle totale est $ 3.18M, composée du salaire de 19.5% et des bonus 80.5%, y compris les actions et options de la société. détient directement 0.3% des actions de la société, d'une valeur de $ 568.21K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.3 ans et 3 ans.

Informations clés

Jeff Hawkins

Directeur général

US$3.2m

Rémunération totale

Pourcentage du salaire du PDG19.50%
Durée du mandat du directeur général3.6yrs
Propriété du PDG0.3%
Durée moyenne d'occupation des postes de direction3.3yrs
Durée moyenne du mandat des membres du conseil d'administration3yrs

Mises à jour récentes de la gestion

Recent updates

Article d’analyse • May 07

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Article d’analyse • Dec 13

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Seeking Alpha • Oct 27

Quantum-Si: Critical 12 Months Ahead

Summary Quantum-Si's fundamentals are weak at the moment, and this likely extends beyond market conditions. This hasn't mattered to the stock, as Quantum-Si's share price is being driven more by sentiment and quantum hype than financial performance. The Proteus system could alter the trajectory of the business, but technology risk is high and there is competition. While I am negative on QSI's prospects, shorting the stock is risky given the company's cash balance, potential positive news on Proteus and rebounding biopharma demand. Read the full article on Seeking Alpha
Article d’analyse • Jun 26

We're Hopeful That Quantum-Si (NASDAQ:QSI) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. By way of example, Quantum-Si...
Seeking Alpha • Mar 11

Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet

Summary Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty. The recent surge in Quantum-Si's share price appears to have been driven more by quantum computing hype than the fundamentals of its business. Read the full article on Seeking Alpha
Seeking Alpha • Jan 04

Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell

Summary Similar to data storage solutions provider Quantum Corporation, life sciences company Quantum-Si appears to be have been picked as a quantum computing play solely due to its name. Since listing on Nasdaq in a backdoor IPO almost four years ago, the company has burned almost $350 million in cash and remains way behind its original business plan. However, Quantum-Si has managed to capitalize on the hype by raising additional funds, thus extending its cash runway by more than one year to late 2027. With the company not involved in quantum computing, I would expect momentum traders to leave for assumed greener pastures sooner rather than later. As a result, I am initiating Quantum-Si's common stock with a "Sell" rating. Read the full article on Seeking Alpha
Seeking Alpha • Dec 29

Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued

Summary Quantum-Si has seemingly surged as part of the quantum computing trend, but its own operating business is not focused on quantum computing. Quantum-Si has badly missed its initial SPAC projections and is struggling to gain commercial momentum. Quantum-Si's balance sheet is healthy for now, but it will likely need more cash by the end of 2026 to commercialize its Platinum platform. Given the unproven business model and potential for a secondary offering, traders would be wise to exit positions now. Read the full article on Seeking Alpha
Seeking Alpha • Dec 16

Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades

Summary Quantum-Si (QSI) has made significant progress in technology and management but missed revenue forecasts for 2024, leading to a revised hold rating. Key partnerships with Nvidia, Planet Innovations, and SkyWater aim to enhance product capabilities, particularly with the upcoming Proteus platform. Despite promising advancements, QSI's commercial traction remains insufficient, delaying profitability and necessitating potential capital raises within two years. The product development roadmap is strong, but substantial revenue growth is crucial for QSI to achieve long-term success and profitability. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

Quantum-Si Is Too Speculative For Me (Technical Analysis)

Summary Quantum-Si has shown bullish price action recently, but I remain skeptical due to its history of bearish trends and potential for a pullback. Short-term momentum is bullish on Quantum-Si stock, but long-term momentum remains bearish, as indicated by the Percentage Price Oscillator (PPO) readings. Volume activity is highly bullish, showing significant institutional interest, yet relative strength remains bearish compared to the S&P 500 index. I recommend waiting for QSI stock to stabilize below the 30-week EMA without making new lows, then reassessing for long-term bullish momentum and institutional buying. Read the full article on Seeking Alpha
Article d’analyse • Nov 06

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Article d’analyse • Aug 03

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Article d’analyse • Apr 19

Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Seeking Alpha • Feb 05

Quantum-Si: Commercial Lift Imminent

Summary Quantum-Si is about to move from a controlled launch to a full scale commercial launch of its first product. It will be a groundbreaking device, a desktop Proteome sequencer at a fraction of the price of competing technology. If the product is successful, QSI stock is likely significantly undervalued. Read the full article on Seeking Alpha
Article d’analyse • Dec 04

Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Article d’analyse • Jun 28

We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Seeking Alpha • Oct 04

Jeff Hawkins is the new CEO of Quantum-Si

Quantum-Si (NASDAQ:QSI) appoints veteran life sciences executive Jeff Hawkins as Chief Executive Officer effective October 10, 2022, succeeding Dr. Jonathan Rothberg, Interim Chief Executive Officer, Founder and Executive Chairman. Most recently Jeff Hawkins was President and Chief Executive Officer of Truvian Sciences.
Seeking Alpha • Sep 24

Quantum-Si: Semiconductor-Based Next Generation Protein Sequencing Platform

Novel semiconductor-based next generation protein sequencing platform targeting $64B+ proteomics market in 2024 (15% CAGR). Founded by Dr. Jonathan Rothberg, Professor of Genetics at Yale University (who sequenced the first human genome and is known for inventing high-speed, next-generation DNA sequencing). The company is planning to commercialize its platform next year and could occupy 10% or more of the proteomics market in 5 years, reaching 10x upside in 5-10 years.

Analyse de la rémunération des PDG

Comment la rémunération de Jeff Hawkins a-t-elle évolué par rapport aux bénéfices de Quantum-Si?
DateRémunération totaleSalaireBénéfices de l'entreprise
Mar 31 2026n/an/a

-US$104m

Dec 31 2025US$3mUS$621k

-US$101m

Sep 30 2025n/an/a

-US$117m

Jun 30 2025n/an/a

-US$106m

Mar 31 2025n/an/a

-US$101m

Dec 31 2024US$4mUS$596k

-US$101m

Sep 30 2024n/an/a

-US$90m

Jun 30 2024n/an/a

-US$89m

Mar 31 2024n/an/a

-US$92m

Dec 31 2023US$1mUS$575k

-US$96m

Sep 30 2023n/an/a

-US$107m

Jun 30 2023n/an/a

-US$114m

Mar 31 2023n/an/a

-US$121m

Dec 31 2022US$8mUS$132k

-US$132m

Rémunération vs marché: La rémunération totale de Jeff ($USD 3.18M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 1.73M ).

Rémunération et revenus: La rémunération de Jeff a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Jeff Hawkins (47 yo)

3.6yrs
Titularisation
US$3,183,693
Compensation

Mr. Jeffrey Alan Hawkins, also known as Jeff, serves as Chief Executive Officer at Quantum-Si incorporated since joining from October 10, 2022 and serves as its Director since October 2022 also serves as i...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Jeffrey Hawkins
President3.6yrsUS$3.18m0.30%
$ 568.2k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 29.0m
Jeffry Keyes
CFO & Treasurer3yrsUS$1.66m0.16%
$ 296.1k
John Vieceli
Chief Product Officer1.8yrsUS$1.46m0.076%
$ 143.3k
Todd Rearick
Chief Technology Officer7.3yrspas de donnéespas de données
Christian Lapointe
General Counsel & Corporate Secretary5.5yrsUS$2.07m0.22%
$ 413.2k
Lindsay Thompson
Chief Human Resources Officer1.8yrspas de donnéespas de données
3.3yrs
Durée moyenne de l'emploi
52yo
Âge moyen

Gestion expérimentée: L'équipe de direction de QSI est considérée comme expérimentée (ancienneté moyenne 3.3 ans).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jeffrey Hawkins
President3.6yrsUS$3.18m0.30%
$ 568.2k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 29.0m
Kevin Rakin
Independent Director5.9yrsUS$203.13k0.0094%
$ 17.7k
Brigid Makes
Independent Director4.9yrsUS$208.75k0.0094%
$ 17.7k
Ruth Fattori
Independent Director5.2yrsUS$213.75k0.078%
$ 146.8k
Charles Kummeth
Independent Chairman2yrsUS$245.00k0.39%
$ 736.1k
Scott Mendel
Independent Director3yrsUS$211.25k0.065%
$ 122.1k
Amir Jafri
Independent Director2.7yrsUS$207.50k0.053%
$ 99.8k
Paula Dowdy
Independent Director2.2yrsUS$202.81k0.12%
$ 231.7k
John Kenny
Independent Director3yrsUS$212.50k0.052%
$ 98.4k
Gloria Sheynkman
Chair of the Scientific Advisory Board1.3yrspas de donnéespas de données
Benjamin Garcia
Member of the Scientific Advisory Board1.3yrspas de donnéespas de données
3.0yrs
Durée moyenne de l'emploi
60.5yo
Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de QSI sont considérés comme expérimentés (ancienneté moyenne 3 ans).

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/20 01:56
Cours de l'action en fin de journée2026/05/20 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Quantum-Si incorporated est couverte par 3 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Scott HenryAlliance Global Partners
Kyle MiksonCanaccord Genuity
Swayampakula RamakanthH.C. Wainwright & Co.